Paras Healthcare IPO

This issue combines a fresh issue and an offer for sale. The amounts for each part are not available in our data; see the offer document for the split.

Lot size and investment

Reservation

QIB

Not more than 75% of the Net Offer

Retail

Not less than 10% of the Offer

NII

Not less than 15% of the Offer

Current GMP

₹52

▲+7.50%

Estimated listing price

₹745

Issue price ₹693

Highest

₹96

17 Oct

Lowest

₹50

20 Oct

GMP by day (₹ per share)

Subject to sauda

₹800 retail · ₹11,200 HNI

GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.

P/E Ratio

37.72

EPS (₹)

18.37

RoE

11.83%

RoCE

4.23%

RoNW

11.83%

PAT Margin

10.38%

EBITDA Margin

23.70%

Debt / Equity

3.21

NAV (₹)

44.06

Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.

Paras Healthcare Limited is a clinical specialty-led hospital platform that provides tertiary and quaternary healthcare through a network of eight hospitals with an aggregate capacity of 2,211 beds as on 31 March 2026. It operates under the Paras Health brand and is based at Paras Twin Towers, Golf Course Road, Sector 54, Gurugram, Haryana. Its critical care infrastructure includes organ and condition-specific ICUs, with 559 ICU beds as on 31 March 2026, up from 425 beds in FY2024. The hospitals employed 1,011 doctors and 1,665 nurses on the same date. The hospitals are spread over five states and one union territory. They are in Gurugram and Panchkula in Haryana, Patna and Darbhanga in Bihar, Kanpur in Uttar Pradesh, Udaipur in Rajasthan, Ranchi in Jharkhand and Srinagar in Jammu and Kashmir. The Gurugram hospital has run for 20 years and the Patna hospital for 12 years, while the newest units at Srinagar and Kanpur have run for three years and two years. Of the eight, four are super-specialty tertiary care hospitals and four are multi-specialty tertiary care hospitals. Six of the eight run on leased premises, five through revenue share arrangements and long-term leases and one under a public private partnership. The business is reported as a single healthcare services segment in a single geography. Work is concentrated in what the company calls CONGOR specialties, meaning cardiac sciences, oncology, neuro sciences, gastro sciences, orthopedics and sports injury, and renal sciences. Together these gave 74.70% of FY2026 revenue from operations, led by oncology at 21.63%, neuro sciences at 13.03% and cardiac sciences at 12.78%. Hospitals outside Gurugram, which the company counts as tier 2 cities, gave 68.18% of FY2026 revenue against 62.35% in FY2024. Operating metrics improved in FY2026. Operational beds rose to 1,502 from 1,465, the bed occupancy rate rose to 61.75% from 50.78%, and occupied bed days rose to 3,38,321 from 2,68,927. In-patient volumes were 1,15,496 and out-patient volumes 7,78,707 in FY2026, against 81,047 and 5,69,139 in FY2024, and the hospitals performed 39,687 surgeries. Average revenue per occupied bed was Rs 47,397.82 per day in FY2026, with the Gurugram hospital at Rs 70,925.76 per day and the Darbhanga hospital at Rs 19,980.75 per day. Average length of stay was 2.93 days. Payments come from three sources. Government schemes and public sector undertakings accounted for 41.28% of FY2026 revenue, self pay patients 33.88% and insurance and third party administrators 24.84%. In FY2024 the same shares were 29.76%, 40.63% and 29.61%. The promoter is Dr. Dharminder Kumar Nagar, the Managing Director, who has been with the company since 2003 and has over 22 years of experience in healthcare. He holds an MBBS from the University of Mysore and a master of philosophy in hospital and health systems management from BITS Pilani.

Objects of the issue

1. Prepayment or scheduled repayment, in full or part, of certain outstanding borrowings of the company₹320.9 Cr
2. Investment in wholly owned subsidiary Plus Medicare Hospitals Private Limited, which runs the Srinagar hospital, for repayment or prepayment of its borrowings₹54.1 Cr
3. General corporate purposes

Promoters and shareholding

Dr. Dharminder Kumar Nagar

Promoter holding, pre-issue

72.80%

Promoter holding, post-issue

—